SecBot SecBot
8-K ·Filed Jun 10, 2026

ELV

Elevance Health, Inc.
NEUTRAL
Impact 2/10
Horizonweeks Processed5mo ago SEC0001156039-26-000049
8-K context-dependent: Items 7.01
Actionable Insight • Neutral

No new information was released, the reaffirmation simply reiterates existing targets. Monitor upcoming quarterly filings for any deviation from the reaffirmed guidance range, particularly around medical cost trends reflected in the 90.2% benefit expense ratio.

DirectionNeutral
Confidencehigh
Horizonweeks

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$404.56
T+0 close · Jun 10, 2026 · via day close
Latest settled
+2.53%
T+60 · $414.78
Vs SPY
−4.05%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jun 10 $404.56entry
  2. T+1 · 5mo ago −1.33%α −3.03% · $399.18
  3. T+5 · 5mo ago −1.67%α −5.10% · $397.80
  4. T+20 · 4mo ago +3.91%α +0.29% · $420.39
  5. T+60 · 2mo ago +2.53%α −4.05% · $414.78
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Elevance Health filed an 8-K to publicly reaffirm its full-year 2026 guidance during investor meetings this week. The company confirmed adjusted EPS of at least $26.75 (and GAAP EPS of at least $19.85) and a benefit expense ratio of 90.2% ±50bps. This is a routine FD disclosure with no new financial data or revisions, merely a reiteration of previously stated targets.

Key Facts

  • Management reaffirmed full-year 2026 GAAP EPS of at least $19.85 per share, including ~$6.90/share of net unfavorable items.
  • Adjusted (non-GAAP) EPS reaffirmed at at least $26.75 per share.
  • Full-year 2026 benefit expense ratio guidance reaffirmed at 90.2% plus or minus 50 basis points.
  • Guidance does not include any adjustment items beyond those reported in Q1 2026 earnings.
  • Filing is a Regulation FD disclosure of investor meeting talking points; no change to prior guidance.

Financial Impact

No financial figures were changed or revised. Reaffirmation of existing guidance at the same levels as previously communicated.

epsbenefit expense ratio

Risk Factors

  • Medical cost trends could deviate from the 90.2% guidance band, pressuring margins.
  • Macroeconomic or regulatory changes could impact enrollment and premium adequacy.

Market Snapshot

Exchange
NYSE
Sector
Hospital & Medical Service Plans
Analyst Consensus
59% bullish (29 analysts)

Investment Themes

Traditional Finance

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001156039-26-000049
Document: 0001156039-26-000049-index-headers.html0001156039-26-000049
Document: 0001156039-26-000049-index.html0001156039-26-000049
Document: 0001156039-26-000049.txt0001156039-26-000049

Track record

19 reports on ELV

Performance horizon

1 of 3 bullish or bearish reports moved the stock their way by T+5. Best: +3.93% at T+5 after the Aug 27, 2026 report. 2 of 3 went positive at some point.

Filters
  1. Nov 10, 20266d ago 8-K Neutral 2/10 Entry $429.48 Now $446.28 +3.91% settles Nov 18
  2. Nov 5, 202611d ago 144 Neutral 2/10 Entry $425.62 to $429.69 Now $446.28 +4.85% ▲ +0.96% −1.64% vs SPY
  3. Oct 28, 202619d ago S-3ASR Neutral 3/10 Entry $422.02 to $432.00 Now $446.28 +5.75% ▲ +2.36% +7.09% vs SPY
  4. Oct 22, 202625d ago 144 Neutral 2/10 Entry $439.95 to $420.07 Now $446.28 +1.44% ▼ −4.52% −3.96% vs SPY
  5. Oct 21, 202626d ago 8-K Bullish 7/10 Entry $434.13 to $421.49 Now $446.28 +2.80% ▼ −2.91% −2.47% vs SPY
  6. Oct 20, 202627d ago Institutional Cluster Neutral 3/10 Entry $434.13 to $421.49 Now $446.28 +2.80% ▼ −2.91% −2.47% vs SPY
  7. Sep 10, 20269w ago 8-K Neutral 3/10 Entry $416.54 to $414.26 Now $446.28 +7.14% ▼ −0.55% −0.05% vs SPY
  8. Aug 27, 202611w ago Institutional Cluster Bullish 6/10 Entry $399.11 to $414.78 Now $446.28 +11.82% ▲ +3.93% +3.66% vs SPY
  9. Aug 20, 202612w ago Court Ruling Neutral 2/10 Entry $400.54 to $394.43 Now $446.28 +11.42% ▼ −1.53% −2.00% vs SPY
  10. Aug 17, 202613w ago Court Ruling Neutral 1/10 Entry $396.54 to $397.14 Now $446.28 +12.54% ▲ +0.15% +0.35% vs SPY
Showing 10 of 19

US Market Status

Market Closed · Opens Wed (11h 13m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 10, 2026